OTCMKTS:PBSV

Pharma-Bio Serv Stock Forecast, Price & News

$1.47

0.00 (0.00 %)

(As of 03/5/2021 12:00 AM ET)

Add

Compare

Today's Range

$1.47

Now: $1.47▼

$1.47

50-Day Range

$1.20

MA: $1.41▼

$1.60

52-Week Range

$0.62

Now: $1.47▼

$2.34

Volume1,009 shs

Average Volume18,926 shs

Market Capitalization$34.45 million

P/E Ratio14.70

Dividend YieldN/A

Beta0.35

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. It provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products in Puerto Rico, the United States, Europe, and Brazil. The company's technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Headlines

Pharma-Bio Serv Announces Results for the Year Ended October 31, 2020
February 1, 2021 | finance.yahoo.com

Pharma-Bio Serv Inc.: Pharma-Bio Serv Announces Appointment of Kirk Michel as Chairman of the Board of Directors and Announces Special Dividend
January 5, 2021 | finanznachrichten.de

Pharma-Bio Serv Announces Appointment of Kirk Michel as Chairman of the Board of Directors and Announces Special Dividend
January 5, 2021 | finance.yahoo.com

PBSV: Pharma-Bio Serv – Looking Ahead to 2021-2022
December 29, 2020 | finance.yahoo.com

Pharma-Bio Serv Inc.
December 2, 2020 | barrons.com

Alpha Bronze LLC: Tetra Bio-Pharma to Present at Alpha Bronze Virtual Town Hall
October 6, 2020 | finanznachrichten.de

Bio Pharma Logistics Market 2020 Global Leading Companies Analysis, Revenue, Trends and Forecasts 2026
September 29, 2020 | marketwatch.com

Ajinomoto Bio-Pharma Services and DNDi Partner to Develop Critical Immunomodulator for Cutaneous Leishmaniasis Therapeutic
September 29, 2020 | prnewswire.com

Erytech Pharma S.A.: ERYTECH establishes a financing facility with the implementation of an at-the-market program on Nasdaq with Cowen
September 21, 2020 | finanznachrichten.de

PBSV: Trump promises to revitalize pharmaceuticals in Puerto Rico
September 21, 2020 | finance.yahoo.com

BioLife Solutions to Acquire SciSafe, a High-Growth Biostorage Service Provider to the Cell and Gene Therapy Industry
September 21, 2020 | prnewswire.com

Viva Biotech's Portfolio Company Dogma Therapeutics Reached the Acquisition Agreement with AstraZeneca on Dogma's Oral PCSK9 Inhibitor Program
September 17, 2020 | prnewswire.com

Pharma-Bio Serv Files 10-Q for the Quarter Ended July 31, 2020
September 14, 2020 | finance.yahoo.com

Bio Pharma Buffer Market By Development, Trends, Investigation 2020 And Forecast To 2026
September 9, 2020 | marketwatch.com

Tetra Bio-Pharma Inc. (TBPMF) Adds Dania Scott as Senior Vice President Commercial Strategy
September 4, 2020 | marketwatch.com

Topical Pain Relief Market Projected to Worth USD 11133.17 million, at a CAGR of 4.31% by 2028|Teikoku Pharma USA, Inc., Topical BioMedics, Inc.
September 3, 2020 | marketwatch.com

Pharmaceutical Lecithin Market 2020 Global Industry Analysis, Size, Share, Growth, Trends, Key Players and Forecast to 2026
August 31, 2020 | marketwatch.com

Tetra Bio-Pharma Announces Data on its CBD Metabolite Study in Humans
August 27, 2020 | finance.yahoo.com

Piramal Pharma Solutions to Collaborate with Epirium Bio on Exclusive Integrated Development & Manufacturing Program for Orphan Drugs
August 27, 2020 | prnewswire.com

Antivenin Market Global Insights and Growing Trend Analysis 2020-2025: Merck, Pfizer, Flynn Pharma, MicroPharm
August 26, 2020 | marketwatch.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Management consulting services

Sub-IndustryN/A

SectorBusiness Services

Current SymbolOTCMKTS:PBSV

Previous Symbol

CUSIPN/A

CIK1304161

Webwww.pharmabioserv.com

Phone787-278-2709

Employees220

Year FoundedN/A

Debt

Debt-to-Equity Ratio0.05

Current Ratio7.62

Quick Ratio7.62

Price-To-Earnings

Trailing P/E Ratio14.70

Forward P/E Ratio11.31

P/E GrowthN/A

Sales & Book Value

Annual Sales$19.51 million

Price / Sales1.77

Cash Flow$0.11 per share

Price / Cash Flow13.92

Book Value$0.88 per share

Price / Book1.67

Profitability

EPS (Most Recent Fiscal Year)$0.09

Net Income$2.09 million

Net Margins11.16%

Return on Equity11.08%

Return on Assets8.55%

Miscellaneous

Outstanding Shares23,433,000

Market Cap$34.45 million

Next Earnings Date3/15/2021 (Estimated)

OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.25 out of 5 stars

Business Services Sector

163rd out of 442 stocks

Management Consulting Services Industry

16th out of 46 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Pharma-Bio Serv.

2.3 Community Rank

Outperform Votes
Pharma-Bio Serv has received 116 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Pharma-Bio Serv has received 137 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Pharma-Bio Serv has received 54.15% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Pharma-Bio Serv and other stocks. Vote “Outperform” if you believe PBSV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PBSV will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Pharma-Bio Serv does not currently pay a dividend.
Dividend Growth
Pharma-Bio Serv does not have a long track record of dividend growth.

0.8 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Pharma-Bio Serv insiders have not sold or bought any company stock.
Percentage Held by Insiders
51.40% of the stock of Pharma-Bio Serv is held by insiders. A high percentage of insider ownership can be a sign of company health.

3.1 Earnings and Valuation

Earnings Growth
Earnings for Pharma-Bio Serv are expected to grow by 23.08% in the coming year, from $0.13 to $0.16 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Pharma-Bio Serv is 14.70, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 31.96.
Price to Earnings Ratio vs. Sector
The P/E ratio of Pharma-Bio Serv is 14.70, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 32.59.
Price to Book Value per Share Ratio
Pharma-Bio Serv has a P/B Ratio of 1.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

$1.47

0.00 (0.00 %)

(As of 03/5/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive PBSV News and Ratings via Email

Sign-up to receive the latest news and ratings for PBSV and its competitors with MarketBeat's FREE daily newsletter.

Pharma-Bio Serv (OTCMKTS:PBSV) Frequently Asked Questions

What stocks does MarketBeat like better than Pharma-Bio Serv?

Wall Street analysts have given Pharma-Bio Serv a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Pharma-Bio Serv wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Pharma-Bio Serv's next earnings date?

Pharma-Bio Serv is scheduled to release its next quarterly earnings announcement on Monday, March 15th 2021.
View our earnings forecast for Pharma-Bio Serv.

How were Pharma-Bio Serv's earnings last quarter?

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) posted its quarterly earnings results on Monday, February, 1st. The company reported $0.01 earnings per share (EPS) for the quarter. The business earned $5.03 million during the quarter. Pharma-Bio Serv had a trailing twelve-month return on equity of 11.08% and a net margin of 11.16%.
View Pharma-Bio Serv's earnings history.

How has Pharma-Bio Serv's stock price been impacted by Coronavirus (COVID-19)?

Pharma-Bio Serv's stock was trading at $0.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, PBSV shares have increased by 72.9% and is now trading at $1.47.
View which stocks have been most impacted by COVID-19.

Who are Pharma-Bio Serv's key executives?

Pharma-Bio Serv's management team includes the following people:

Mr. Victor Sanchez, CEO, Pres & Pres of European Operations (Age 50, Pay $235.55k)
Ms. Elizabeth Plaza, Founder & Sr. Strategic Consultant (Age 57, Pay $539.67k)
Mr. Pedro J. Lasanta, CFO, VP of Fin. & Admin. and Sec. (Age 61, Pay $186.18k)
Ms. Nelida Plaza, Operations Pres (Age 53)
Ms. Miriam Marrero M.B.A., HR Mang.

Who are some of Pharma-Bio Serv's key competitors?

Some companies that are related to Pharma-Bio Serv include Avalon GloboCare (AVCO), TransAtlantic Capital (TACI), ATIF (ATIF), Cyber Apps World (CYAP), Wilhelmina International (WHLM), Lightbridge (LTBR), Hudson Capital (HUSN), Ashford (AINC), TSS (TSSI), Gopher Protocol (GOPH), GBT Technologies (GTCH), 6D Global Technologies (SIXD), Grow Solutions (GRSO), DigiPath (DIGP) and root9B (RTNB).
View all of PBSV's competitors.

What other stocks do shareholders of Pharma-Bio Serv own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pharma-Bio Serv investors own include Zynerba Pharmaceuticals (ZYNE), Allena Pharmaceuticals (ALNA), AstroNova (ALOT), Oracle (ORCL), AT&T (T), Yintech Investment (YIN), Aeglea BioTherapeutics (AGLE), Ampliphi Biosciences (APHB), Carnival Co. & (CCL) and Earthstone Energy (ESTE).

What is Pharma-Bio Serv's stock symbol?

Pharma-Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV."

How do I buy shares of Pharma-Bio Serv?

Shares of PBSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pharma-Bio Serv's stock price today?

One share of PBSV stock can currently be purchased for approximately $1.47.

How much money does Pharma-Bio Serv make?

Pharma-Bio Serv has a market capitalization of $34.45 million and generates $19.51 million in revenue each year. The company earns $2.09 million in net income (profit) each year or $0.09 on an earnings per share basis.

How many employees does Pharma-Bio Serv have?

Pharma-Bio Serv employs 220 workers across the globe.

What is Pharma-Bio Serv's official website?

The official website for Pharma-Bio Serv is www.pharmabioserv.com.

Where are Pharma-Bio Serv's headquarters?

Pharma-Bio Serv is headquartered at Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646.

How can I contact Pharma-Bio Serv?

Pharma-Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The company can be reached via phone at 787-278-2709 or via email at [email protected]

This page was last updated on 3/6/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here